Reach Us +1-504-608-2390
Multifocal Choroiditis with Panuveitis | OMICS International
ISSN: 2155-9570
Journal of Clinical & Experimental Ophthalmology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Multifocal Choroiditis with Panuveitis

Ghyath Kafa*
Department of Ophthalmology, County Durham and Darlington Foundation Trust, United Kingdom
Corresponding Author : Ghyath Kafa
speciality doctor, ophthalmology
Manchester, United Kingdom
Tel: 00447894525356
E-mail: [email protected]
Received: May 22, 2015 Accepted: September 21, 2015 Published: September 26, 2015
Citation: Kafa G (2015) Multifocal Choroiditis with Panuveitis. J Clin Exp Ophthalmol 6:479. doi:10.4172/2155-9570.1000479
Copyright: © 2015 Kafa G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at Pubmed, Scholar Google

Visit for more related articles at Journal of Clinical & Experimental Ophthalmology

A 57 years old myopic healthy woman came to the urgent care in Darlington Memorial Hospital, UK for follow up after anterior uveitis in her left eye. She was on topical steroids and cycloplegic for her left eye. The patient has been complaining of floaters and recurrent onset of decreased vision in both eyes since 1999. She has also a long history of recurrent anterior uveitis and vitritis in both eyes. She had a history of bilateral cystoid macular oedema in both eyes starting about 6 months ago which was treated successfully with topical NASIDs and topical steroids (Figure 1).
On examination visual acuity in the right eye was 6/6 and in the left eye was 6/7.5. The intraocular pressure was 16 mmHg in the right eye and 15 in the left eye. The ocular motilities were normal.
Slit lamp examination for the right eye showed a clear cornea, deep and quiet anterior chamber. The lens showed some pigment deposits on anterior lens surface and mild cataract. The vitreous had debris with no active vitritis, and the fundus showed peripappillary atrophy. However, slit lamp examination of the left eye showed mild anterior chamber reaction with a pharmacologically dilated pupil and some pigment deposits on anterior lens surface. The vitreous had debris with no active vitritis. The fundus showed peripappillary atrophy, round pigmented atrophic chorioretinal scars, and white active choroidal lesions at the posterior pole and mid peripheral fundus (Figure 2).
Ancillary tests
FBC, ESR, CRP, ACE, chest X-rays were normal, FTA-ABS was negative. Tuberculin skin test and interferon gamma were negative.
The patient was not started on oral steroid due to good visual acuity in the affected eye and was just prescribed topical steroids and cyclplegics.
Follow up after two months showed complete settling of inflammation disappeared with vision back to normal. The new OCT showed a normal dry macula with no intraretinal fluid in either eye. (Figure 3).
Differential diagnosis
Punctuate inner choroidopathy
Multifocal choroiditis with pan uveitis
Presumed ocular histoplasmosis
Infectious diseases like TB
Inflammatory diseases like sarcoidosis
Others like intraocular lymphoma
Diagnosis and Discussion
The patient has multifocal choroiditis with pan uveitis. The diagnosis is one of exclusion as many other conditions, such as, punctate inner choroidopathy, presumed ocular histoplasmosis, sarcoidosis, syphilis, and tuberculosis, may produce lesions similar in appearance to those of MCP. Sometimes the diagnosis is considered a dilemma and a new study has suggested invasive procedures such as chorioretinal biopsy to confirm the diagnosis [1].
We excluded punctuate inner choroidopathy for two reasons. Firstly, PIC usually comes in younger ages and with lower frequencies of structural complications from intraocular inflammation and a lower frequency of visual impairment at presentation [2]. Our patient had the first onset when she was 42 years old. Secondly, Punctate inner choroidopathy is characterized by smaller yellowish spots (50-100 microns) located at the level of the retinal pigment epithelium and inner choroid, most often located in the posterior pole as firstly described in 1984 [3]. Our patient has lesions at the posterior pole and peripeherally and the lesions are around 200 microns. The case also mimcs POHS, however, in our patient , there is no history of living in areas endemic for POHS, and the latter rarely comes with anterior uveitis [4,5]. TB and sarcoidosis should be included in the differential diagnosis [6]. We excluded them as the patient is healthy and has longstanding history of this problem without any other associated relevant systemic problems. Furthermore, blood, immunology, histochemistry tests and chest x-rays were normal. We ruled out intraocular lymphoma for three reasons. Firstly, because the indolent course of the uveitis in our patient. Secondly, intraocular lymphoma comes in older ages. Finally, lack of CMO is an important diagnostic clue, since in true uveitis significant vitritis is almost always accompanied by CMO.
Treatment options are topical, periocular injection,and/ or systemic steroids . Also, many studies say that Immunomodulatory therapy controls inflammation and preserves vision in patients with multifocal choroiditis and panuveitis [7]. However, as our patient has a good history of gaining complete recovering after topical steroids and NASID for OCT, we prefer to stay using topical treatment for this condition. Finally, it is important to mention that there is a current study of using an intravitreal injection of LFG316 and to assess the safety, tolerability and effect of this drug in patients with active Multifocal Choroiditis and Panuveitis. LFG316 5 mg administered via IVT (intravitreally) on Days 1 29 and 57 (LFG316 is a complement inhibitor that targets the complement system at C5) [8].

Figures at a glance

Figure Figure Figure
Figure 1 Figure 2 Figure 3
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 12461
  • [From(publication date):
    October-2015 - Dec 06, 2019]
  • Breakdown by view type
  • HTML page views : 8623
  • PDF downloads : 3838